BOARD

Board of Directors

Duccio Neri

Duccio Neri is Co-founder and Chairman of Philogen. He graduated in Business Administration and Economics at the Bocconi University in Milan, specializing in Corporate Finance. Dr. Neri has a special expertise in Financial Consulting, Tax and Audit Advice and Business Administraton and is a Partner of the “Studio Neri – Tanini”. He was a representative of the Italian Government in the Board of the University of Siena and an auditor of the Cassa di Risparmio di San Miniato (CRSM) S.p.A., MPS Banca Verde S.p.A., MPS Fiduciaria S.p.A., MPS Professional S.p.A., and of several other firms.

Dario Neri

Dario Neri is Co-founder, CEO, CSO and President of the Scientific Advisory Board of Philogen. He graduated in Chemistry at the Scuola Normale Superiore in Pisa and obtained his PhD in Chemistry from the ETH Zürich, under the supervision of Prof. Kurt Wüthrich, winner of the Nobel Prize for Chemistry in 2002. For his dissertation, he was awarded the Silver Medal of ETH. After a 5 years post-doctoral research position in the lab of 2018 Chemistry Nobel Price Winner Sir Gregory Winter at the Cambridge Centre of Protein Engineering in Cambridge, UK, he returned to ETH Zürich in 1996 as Assistant Professor in Molecular Structure Biology.
Since 1999, he has been a Professor of Biomacromolecules in the department of Chemistry and Applied Biosciences at ETH Zürich.
Prof. Neri is the recipient of the ISOBM Abbott Prize 2000, of the Amgen-Dompe' Biotec Award 2000, of the Mangia d'Oro 2001, of the Prous Award 2006 of the European Federation of Medicinal Chemistry, of the Robert-Wenner-Prize 2007 of the Swiss Cancer League, of the SWISS BRIDGE Award 2008, of the Prix Mentzer 2011 of the French Medicinal Chemistry Society, of the Phoenix Prize 2014 and of an ERC Advanced Grant 2015. Prof. Neri is author of more than 400 publications in international scientific journals.

Emanuele Puca

Emanuele Puca graduated in Medicinal Chemistry at La Sapienza University. He performed his PhD studies at ETH Zürich focusing on the generation of antibody-cytokine fusion proteins for the treatment of extracranial and brain tumors. Dr. Puca is author of several peer-reviewed publications in international scientific journals.

x

By continuing to browse or by closing this window, you accept the use of cookies.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. By closing this banner or continuing to browse, you agree to the use of cookies.

I Accept Cookie Policy
X